Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
16.00
+0.30
+(1.89%)
At close: February 21 at 5:29:42 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-162,883
-209,186
-192,076
-75,353
Investing Cash Flow
--
--
--
-131
Financing Cash Flow
655,474
122,892
226,146
4,953
End Cash Position
644,010
87,972
173,546
138,202
Capital Expenditure
--
--
--
-131
Issuance of Capital Stock
715,000
--
242,606
5,148
Issuance of Debt
--
124,343
--
--
Free Cash Flow
-162,883
-209,186
-192,076
-75,484
12/31/2021 - 6/20/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EQL.ST EQL Pharma AB
83.80
+1.21%
SECARE.ST Swedencare AB (publ)
46.08
+0.88%
MRK.BE Merck KGaA
135.95
+1.15%
SOBI.ST Swedish Orphan Biovitrum AB (publ)
312.40
-1.08%
MOB.ST Moberg Pharma AB (publ)
9.06
-0.06%
INDV.L Indivior PLC
688.50
-5.94%
AQST Aquestive Therapeutics, Inc.
3.0100
-1.63%
BHC Bausch Health Companies Inc.
7.31
+1.81%
TEVA Teva Pharmaceutical Industries Limited
16.74
-1.53%